Pradžia › Stargardto liga › Florida
Stargardto liga klinikiniai tyrimai Florida
8 tyrimai dėl Stargardto liga ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
Renkami dalyviai1/2 fazė
Amžius nuo 8 iki 55 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
Renkami dalyviai3 fazė
Amžius nuo 8 iki 45 · Visoms lytims · Atnaujinta 2026-09-18 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
Renkami dalyviaiStebimasis tyrimas
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07425574Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
Renkami dalyviaiStebimasis tyrimas
Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2026-03-11 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2025-12-02 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 12 iki 65 · Visoms lytims · Atnaujinta 2025-09-19 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 65 · Visoms lytims · Atnaujinta 2025-04-29 · NCT06942572Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.